PowerUp Acquisition postpones extension vote to May 22; enters non-redemption agreements to limit trust redemptions

Aspire Biopharma Holdings, Inc.

Extraordinary general meeting further postponed to 2:00 p.m. ET on May 22, 2024 to vote on extending business combination deadline to Feb. 17, 2025.
Shareholders may submit or withdraw redemption requests by 5:00 p.m. ET on May 20, 2024 (same day as filing).
Sponsor SRIRAMA Associates enters non-redemption agreements; for every 150,000 non-redeemed shares, sponsor transfers 50,000 Class A shares to agreeing shareholders.
Non-redemption agreements aim to increase funds remaining in trust account after the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.